Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Repeated Intra-Articular Injection of SI-613 in Patients With Osteoarthritis of the Knee
Conditions
Interventions
SI-613
Placebo
Locations
10
United States
Tucson Orthopaedic Institute
Tucson, Arizona, United States
MM Medical Center, Inc.
Miami, Florida, United States
Quality Research and Medical Center, LLC
Miami, Florida, United States
Heartland Research Associates, LLC
Newton, Kansas, United States
Central Kentucky Research Associates
Lexington, Kentucky, United States
Sundance Clinical Research, LLC
St Louis, Missouri, United States
Start Date
October 19, 2017
Primary Completion Date
August 17, 2018
Completion Date
November 13, 2018
Last Updated
November 4, 2021
NCT07364578
NCT06488144
NCT07058623
NCT06083480
NCT06955481
NCT06208631
Lead Sponsor
Seikagaku Corporation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions